Anthera Pharmaceuticals Inc (ANTH PINK) stock market data APIs
$0.0001
0(0%)
as of November 3, 2025
Try our APIs with
free plan!
Anthera Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.
Prev. Close
0.0001
Open
0.0001
High
0.0001
Low
0.0001
52 wk Range
0.0001-0.001
Market Cap
618 K
Shares Outstanding
26 179 K
EPS
0
Beta
-87.927
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Anthera Pharmaceuticals Inc data using free add-ons & libraries
Get Anthera Pharmaceuticals Inc Fundamental Data
Anthera Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -36 402 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-18
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Anthera Pharmaceuticals Inc News
New
Fiserv's exec shakeup, Anthropic to use Amazon data center chips
Market Domination host Josh Lipton tracks several of the day's top trending stock tickers, including Caterpillar's (CAT) stock gains on its strong third quarter earnings results and upbeat outlook, Fi...
Goldman: Small businesses using AI say it has a positive impact — and not because it is replacing workers
There’s no shortage of economic uncertainty for the country’s small businesses, but many are surprisingly upbeat about the year ahead. A source for that optimism: artificial intelligence. That’...
Trilogy Metals stock up over 200%, Seaport upgrades Netflix
Market Domination host Josh Lipton and Aptus Capital Advisors head of equity and portfolio manager David Wagner track several of the day's top trending stock tickers, including Trilogy Metals (TMQ) af...
IBM enters AI partnership with Anthropic, fire disrupts Ford
Market Catalysts host Julie Hyman tracks several of the day's top trending stock tickers, including International Business Machines' (IBM) new AI partnership with Anthropic (ANTH.PVT), Ford (F) projec...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
